Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemia
about
γ-Secretase inhibitors and modulators.From fly wings to targeted cancer therapies: a centennial for notch signalingThe Notch pathway: a crossroad between the life and death of the endotheliumThe novel ubiquitin ligase complex, SCF(Fbxw4), interacts with the COP9 signalosome in an F-box dependent manner, is mutated, lost and under-expressed in human cancersAn epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia.Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patientsShort hairpin RNA targeting Notch2 inhibits U87 human glioma cell proliferation by inducing cell cycle arrest and apoptosis in vitro and in vivo.Beyond the 2008 World Health Organization classification: the role of the hematopathology laboratory in the diagnosis and management of acute lymphoblastic leukemiaMOHITO, a novel mouse cytokine-dependent T-cell line, enables studies of oncogenic signaling in the T-cell contextGene expression profiles in BCL11B-siRNA treated malignant T cells.Clinical and molecular characterization of early T-cell precursor leukemia: a high-risk subgroup in adult T-ALL with a high frequency of FLT3 mutationsPharmacogenomics and cancer stem cells: a changing landscape?Molecular pathogenesis of mantle cell lymphoma.Molecular pathogenesis of chronic lymphocytic leukemia.Bromodomain and hedgehog pathway targets in small cell lung cancer.MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid MalignanciesUTX inhibition as selective epigenetic therapy against TAL1-driven T-cell acute lymphoblastic leukemiaThe clerodane diterpene casearin J induces apoptosis of T-ALL cells through SERCA inhibition, oxidative stress, and interference with Notch1 signaling.CDK6-mediated repression of CD25 is required for induction and maintenance of Notch1-induced T-cell acute lymphoblastic leukemia.Notch1 signaling is involved in regulating Foxp3 expression in T-ALL.Exploiting the Epigenome to Control Cancer-Promoting Gene-Expression Programs.Chronic lymphocytic leukemia: molecular heterogeneity revealed by high-throughput genomicsDifferential gene expression profiles of PPP2R5C-siRNA-treated malignant T cells.Targeting Notch-1 positive acute leukemia cells by novel fucose-bound liposomes carrying daunorubicin.Novel targets for treatment of adult acute lymphocytic leukemia.Protein kinase networks regulating glucocorticoid-induced apoptosis of hematopoietic cancer cells: fundamental aspects and practical considerations.Therapeutic potential of Notch inhibition in T-cell acute lymphoblastic leukemia: rationale, caveats and promises.Jagged-1: a new promising factor associated with favorable prognosis in patients with acute myeloid leukemia.Notch pathway plays a novel and critical role in regulating responses of T and antigen-presenting cells in aGVHD.
P2860
Q26830462-B9E55D1B-C6F1-4FF2-9228-691AD8004173Q27004534-CA12635B-731B-4F79-8884-1F84B6DA4088Q27027476-9CD8B19F-59F3-4623-A449-04D549224F34Q28487539-5F982B34-1073-4E93-BCA8-9C367B1DD781Q33864145-ADDE1B56-E3FF-424E-8125-59C383F6BBB1Q34469099-6FCAF483-43D3-41E4-B945-46D704DCFD6DQ34487956-DFA46D08-3A31-4EAB-AF08-CA7AC5DBFFB3Q34755687-6A543686-BD4C-4E2C-847E-71D11969670DQ34890636-49379621-2C9B-4422-A201-DE58527E9812Q35041552-B10B2A44-EA48-427F-A713-9775E5DD98BCQ35723764-E44BD104-AD25-4E29-AA62-4DF389C8FE86Q36251549-92E2BEF6-8E94-4A67-B2C4-B2DEF3B92744Q36290246-85BAF7FC-5236-46F7-B58F-01C8E6FD17EEQ36290321-FF6CD3E5-3131-4B0A-93C3-DCEB45DE59A7Q36535682-2FF7B8F2-3999-4105-A9AF-3EEE0559AF5BQ36602853-842E7578-D64D-4D21-9AA3-57D0FD23F275Q36661533-3E6E49CA-BA28-41B7-A407-F5A485F4610CQ36751787-702886B5-866C-4B20-BDAE-AA9EE956F7C5Q36869358-DF4A425F-8373-4241-AC8E-2BA8111C11B9Q36874225-01A73259-A32E-40EC-999F-C64C4480D5BDQ36956610-51281582-5A11-4F91-B3F3-78FC3BCAAFC3Q36998431-B2D03F07-FDFD-4243-89D4-0E967A2F0E86Q37202568-5EF302EC-0596-40B6-8CC3-38598D86F9DEQ37437588-81E4CD63-2252-4570-9FB9-559F4DDB6B36Q37777362-2B6546D1-F336-4ACF-8BC9-311FBB3E6556Q37789771-48BEEC4A-05D4-4CB6-95B7-FEEA5FD58D95Q37934968-669387F3-4C84-4D67-B539-E2A0969F2A9CQ46137752-81B414EA-5D13-4086-BAFF-136DDB9FA6FCQ51369795-814EC505-0427-4768-A81F-1F1F70B47052
P2860
Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemia
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemia
@ast
Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemia
@en
type
label
Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemia
@ast
Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemia
@en
prefLabel
Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemia
@ast
Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemia
@en
P2860
P356
P1476
Therapeutic targeting of NOTCH1 signaling in T-cell acute lymphoblastic leukemia
@en
P2093
Adolfo Ferrando
Teresa Palomero
P2860
P304
P356
10.3816/CLM.2009.S.013
P478
P577
2009-01-01T00:00:00Z